glp-1 combination therapy Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment 📢 New Resource Alert! single_pack Sample collection:Home appointment (add £70)

glp-1 combination therapy Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment 📢 New Resource Alert! single_pack Sample collection:Home appointment (add £70)

📢 New Resource Alert! We've added an important update to our Resource Library: Changes to GLP‑1 coverage under Pennsylvania Medicaid If you or someone you support uses GLP‑1 medications and you are

Last Published 04.01.2026 Effective Date: 04.01.2026 – This policy addresses the use of somatostatin analogs, including Sandostatin® (octreotide acetate), Sandostatin® LAR (octreotide acetate LAR), Signifor® (pasireotide diaspartate), Signifor® LAR (pasireotide), and Somatuline® Depot (lanreotide), and Lanreotide Injection

single_pack

Sample collection:Home appointment (add £70)

EGEMS (Wash DC)